Lu Han
Director, Business Development Asia Pacific @ Lumira Ventures
Toronto, Canada
Lu Han is a Series A investor at Lumira Ventures in Toronto focused on Biopharma and Therapeutics. Lu is passionate about helping entrepreneurs achieving their goals being a co-founder of a start-up company prior to joining Lumira Ventures in late 2014 as an analyst and later promoted to Director in 2017.Lu focusses on deal sourcing, due diligence and partnership initiatives in China and Asia for Lumira portfolio companies and assists in fundraising initiatives.Prior to joining Lumira, Lu was a co-founder and vice president, business strategy and operations, at Sound Options Tinnitus Treatment Inc. Prior to this, Lu was a strategic consultant at a boutique consultancy firm in the healthcare and life sciences sector, covering both Canadian and International markets. He’s been involved in various education development initiatives in China including a pilot project that recruits and trains outstanding Chinese and Canadian University students to serve as summer school teachers in rural communities of China’s western provinces. Lu received his Ph.D. in neuroscience from the University of Toronto studying under Prof Michael Salter. Lu also holds a B.Sc. in medical sciences from Western University.Lu is fluent in English and Mandarin Chinese.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Lu Han invests in
Stages Lu Han invests in
Countries Lu Han invests in
Investment Focus
Industry
- Biopharma 1 (50%)
- Therapeutics 1 (50%)
- Biotechnology 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
AmacaThera
|
AmacaThera is a clinical-stage company based in Toronto. AmacaThera is redefining how therapeutics are delivered. AmacaThera has developed a platform hydrogel technology that addresses the critical problem of sustaining therapeutic delivery of pharmacological agents for multiple disease areas. AmacaThera’s lead product addresses post-operative painand consequently may have an impact on the opioid crisis. | $2.9M / Series A / Nov 28, 2023 | |
|
AmacaThera
|
AmacaThera is a clinical-stage company based in Toronto. AmacaThera is redefining how therapeutics are delivered. AmacaThera has developed a platform hydrogel technology that addresses the critical problem of sustaining therapeutic delivery of pharmacological agents for multiple disease areas. AmacaThera’s lead product addresses post-operative painand consequently may have an impact on the opioid crisis. | $10.3M / Series A / Feb 22, 2021 |
Co-Investors
About Lumira Ventures
With a 30-year reputation as a leading North American healthcare and life sciences venture capital firm, with offices in Toronto, Montreal, Vancouver and Boston, Lumira Ventures collaborates with and invests in entrepreneurial management teams to build best-in-class, innovation-centric biotherapeutic and medical device companies that are meetingsignificant unmet needs and creating transformation impact in communities worldwide.Since 1989, Lumira Ventures has invested in over 100 healthcare companies and currently has a portfolio of 30+ active investee companies located in Canada and the United States.
Lumira Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Baye Galligan, M.A., HBA
Associate
|
|||
Benjamin Rovinski
Managing Director
|
|||
Brian J. Underdown, Ph.D.
Venture Partner
|
|||
Daniel Hetu
Managing Director
|
|||
|
Lu Han
Director, Business Development Asia Pacific
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Lu Han invest in?
Lu Han invests primarily in Biopharma, Therapeutics and Biotechnology startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Lu Han last invest?
The most recent investment recorded for Lu Han closed in Nov 2023. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
